Publications by authors named "Nami Tagami"

Claim this Profile
I
Isatuximab plus pomalidomide and dexamethasone in frail individuals with relapsed/refractory multiple myeloma in Japan.
Nami Tagami, Michihiro Uchiyama, Kenshi Suzuki, Heigoroh Shirai, Takeshi Seto

Int J Hematol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current status of BAFF targeting immunotherapy in B-cell neoplasm.
Nami Tagami, Junichiro Yuda, Yasuyuki Goto

Int J Clin Oncol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isatuximab with pomalidomide-dexamethasone in relapsed/refractory multiple myeloma: post-marketing surveillance in Japan.
Nami Tagami, Michihiro Uchiyama, Kenshi Suzuki, Heigoroh Shirai, Takeshi Seto

Int J Hematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis